164 related articles for article (PubMed ID: 24609898)
1. The function of EMSY in cancer development.
Hou J; Wang Z; Yang L; Guo X; Yang G
Tumour Biol; 2014 Jun; 35(6):5061-6. PubMed ID: 24609898
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of EMSY gene amplification in human cancers.
Wilkerson PM; Dedes KJ; Wetterskog D; Mackay A; Lambros MB; Mansour M; Frankum J; Lord CJ; Natrajan R; Ashworth A; Reis-Filho JS
J Pathol; 2011 Sep; 225(1):29-42. PubMed ID: 21735447
[TBL] [Abstract][Full Text] [Related]
3. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.
Cousineau I; Belmaaza A
Mol Genet Genomics; 2011 Apr; 285(4):325-40. PubMed ID: 21409565
[TBL] [Abstract][Full Text] [Related]
4. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
Hughes-Davies L; Huntsman D; Ruas M; Fuks F; Bye J; Chin SF; Milner J; Brown LA; Hsu F; Gilks B; Nielsen T; Schulzer M; Chia S; Ragaz J; Cahn A; Linger L; Ozdag H; Cattaneo E; Jordanova ES; Schuuring E; Yu DS; Venkitaraman A; Ponder B; Doherty A; Aparicio S; Bentley D; Theillet C; Ponting CP; Caldas C; Kouzarides T
Cell; 2003 Nov; 115(5):523-35. PubMed ID: 14651845
[TBL] [Abstract][Full Text] [Related]
5. The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
Viré E; Curtis C; Davalos V; Git A; Robson S; Villanueva A; Vidal A; Barbieri I; Aparicio S; Esteller M; Caldas C; Kouzarides T
Mol Cell; 2014 Mar; 53(5):806-18. PubMed ID: 24582497
[TBL] [Abstract][Full Text] [Related]
6. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.
Navazio AS; Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Tommasi S; Palli D; Ottini L
Breast Cancer Res Treat; 2016 Nov; 160(1):181-186. PubMed ID: 27628328
[TBL] [Abstract][Full Text] [Related]
7. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL
Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470
[TBL] [Abstract][Full Text] [Related]
8. Expression of EMSY gene in sporadic ovarian cancer.
Altinisik J; Karateke A; Coksuer H; Ulutin T; Buyru N
Mol Biol Rep; 2011 Jan; 38(1):359-63. PubMed ID: 20349280
[TBL] [Abstract][Full Text] [Related]
9. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.
Brown LA; Johnson K; Leung S; Bismar TA; Benítez J; Foulkes WD; Huntsman DG
Breast Cancer Res Treat; 2010 Jun; 121(2):347-54. PubMed ID: 19636701
[TBL] [Abstract][Full Text] [Related]
10. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
[TBL] [Abstract][Full Text] [Related]
11. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations of CCND1 and EMSY in breast cancers.
Kirkegaard T; Nielsen KV; Jensen LB; Campbell FM; Müller S; Tovey SM; Brown S; Cooke TG; Bartlett JM
Histopathology; 2008 May; 52(6):698-705. PubMed ID: 18393977
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY.
Raouf A; Brown L; Vrcelj N; To K; Kwok W; Huntsman D; Eaves CJ
J Natl Cancer Inst; 2005 Sep; 97(17):1302-6. PubMed ID: 16145051
[TBL] [Abstract][Full Text] [Related]
14. Clarifying the role of EMSY in DNA repair in ovarian cancer.
Kondrashova O; Scott CL
Cancer; 2019 Aug; 125(16):2720-2724. PubMed ID: 31154666
[No Abstract] [Full Text] [Related]
15. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
Rodriguez C; Hughes-Davies L; Vallès H; Orsetti B; Cuny M; Ursule L; Kouzarides T; Theillet C
Clin Cancer Res; 2004 Sep; 10(17):5785-91. PubMed ID: 15355907
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer.
Mulrane L; Gallagher WM; O'Connor DP
Breast Cancer Res; 2014 Nov; 16(6):467. PubMed ID: 25927669
[TBL] [Abstract][Full Text] [Related]
17. EMSY promoted the growth and migration of ovarian cancer cells.
Zhao X; Zhou Y; Nie M; Xian S; Chen H; Wen Y; Zhang L; Huang Y; Chen M; Wang S
Tumour Biol; 2015 Apr; 36(4):3085-92. PubMed ID: 25510665
[TBL] [Abstract][Full Text] [Related]
18. The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair.
Jelinic P; Eccles LA; Tseng J; Cybulska P; Wielgos M; Powell SN; Levine DA
Oncotarget; 2017 Feb; 8(8):13792-13804. PubMed ID: 28099152
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the ENT domain of human EMSY.
Chavali GB; Ekblad CM; Basu BP; Brissett NC; Veprintsev D; Hughes-Davies L; Kouzarides T; Itzhaki LS; Doherty AJ
J Mol Biol; 2005 Jul; 350(5):964-73. PubMed ID: 15978617
[TBL] [Abstract][Full Text] [Related]
20. Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69.
Ekblad CM; Chavali GB; Basu BP; Freund SM; Veprintsev D; Hughes-Davies L; Kouzarides T; Doherty AJ; Itzhaki LS
EMBO Rep; 2005 Jul; 6(7):675-80. PubMed ID: 15947784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
